About rani therapeutics holdings inc - RANI
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
RANI At a Glance
Rani Therapeutics Holdings, Inc.
2051 Ringwood Avenue
San Jose, California 95131
| Phone | 1-408-457-3700 | Revenue | 1.03M | |
| Industry | Biotechnology | Net Income | -30,018,000.00 | |
| Sector | Health Technology | Employees | 105 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
RANI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 37.95 |
| Price to Book Ratio | 22.99 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.866 |
| Enterprise Value to Sales | 40.937 |
| Total Debt to Enterprise Value | 0.706 |
RANI Efficiency
| Revenue/Employee | 9,790.476 |
| Income Per Employee | -285,885.714 |
| Receivables Turnover | 1.637 |
| Total Asset Turnover | 0.022 |
RANI Liquidity
| Current Ratio | 1.495 |
| Quick Ratio | 1.495 |
| Cash Ratio | 1.415 |
RANI Profitability
| Gross Margin | N/A |
| Operating Margin | -4,824.903 |
| Pretax Margin | -5,504.28 |
| Net Margin | -2,920.039 |
| Return on Assets | -63.497 |
| Return on Equity | -404.065 |
| Return on Total Capital | -94.691 |
| Return on Invested Capital | -114.154 |
RANI Capital Structure
| Total Debt to Total Equity | 1,491.416 |
| Total Debt to Total Capital | 93.716 |
| Total Debt to Total Assets | 81.097 |
| Long-Term Debt to Equity | 665.161 |
| Long-Term Debt to Total Capital | 41.797 |